BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7428153)

  • 1. Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
    Wung WE; Howell SB
    Clin Chem; 1980 Nov; 26(12):1704-8. PubMed ID: 7428153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
    Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
    J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-performance liquid chromatographic method for the determination of hypoxanthine, xanthine, uric acid and allantoin in serum.
    Kock R; Delvoux B; Greiling H
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):303-10. PubMed ID: 8357939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma oxipurinol concentrations during allopurinol therapy.
    Emmerson BT; Gordon RB; Cross M; Thomson DB
    Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversed-phase liquid-chromatographic determination of purine compounds in serum applied to studies of hypouricemia.
    Kojima T; Nishina T; Kitamura M; Kamatani N; Nishioka K
    Clin Chem; 1986 Feb; 32(2):287-90. PubMed ID: 3943189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of hypoxanthine in plasma from patients with ischemic heart disease: adaption of a high-performance liquid chromatographic method.
    Himmel HM; Sadony V; Ravens U
    J Chromatogr; 1991 Jul; 568(1):105-15. PubMed ID: 1770088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of guanine, uric acid, hypoxanthine and xanthine in human plasma by reversed-phase high-performance liquid chromatography with amperometric detection.
    Liu Z; Li T; Wang E
    Analyst; 1995 Aug; 120(8):2181-4. PubMed ID: 7677251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
    Yamanaka H; Nishioka K; Suzuki T; Kohno K
    Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
    Reinders MK; Nijdam LC; van Roon EN; Movig KL; Jansen TL; van de Laar MA; Brouwers JR
    J Pharm Biomed Anal; 2007 Oct; 45(2):312-7. PubMed ID: 17890037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of allopurinol, oxipurinol, hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography.
    Boulieu R; Bory C; Baltassat P; Gonnet C
    J Chromatogr; 1984 May; 307(2):469-74. PubMed ID: 6736196
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.
    Turnheim K; Krivanek P; Oberbauer R
    Br J Clin Pharmacol; 1999 Oct; 48(4):501-9. PubMed ID: 10583019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of hypoxanthine and xanthine in biological fluids.
    Boulieu R; Bory C; Baltassat P; Gonnet C
    J Chromatogr; 1982 Dec; 233():131-40. PubMed ID: 6897651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of allopurinol and oxipurinol in biological fluids by mass fragmentography.
    Lartigue-Mattei C; Chabard JL; Bargnoux H; Petit J; Berger JA
    J Chromatogr; 1982 Apr; 229(1):211-6. PubMed ID: 7085828
    [No Abstract]   [Full Text] [Related]  

  • 14. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
    Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
    Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
    Hosoya T; Ichida K; Tabe A; Sakai O
    Ryumachi; 1991 Feb; 31(1):28-35. PubMed ID: 1857993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glucagon on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
    J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
    McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
    Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatography with polarographic and voltammetric anodic detection: simultaneous determination of allopurinol, oxipurinol and uric acid in body fluids.
    Palmisano F; Desimoni E; Zambonin PG
    J Chromatogr; 1984 Mar; 306():205-14. PubMed ID: 6715459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assay of hypoxanthine, xanthine and allopurinol by high-performance liquid chromatography and activation of immobilized xanthine oxidase as an enzyme reactor.
    Kito M; Tawa R; Takeshima S; Hirose S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2459-62. PubMed ID: 2605692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
    Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
    Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.